Jinling Pharmaceutical (000919.SZ) subsidiary paid back taxes of 8.4115 million yuan.

17:07 12/02/2026

Jinling Pharmaceuticals (000919.SZ) announced that its controlling subsidiary, Suqian Hospital Group of Nanjing Gulou Hospital Group Suqian Hospital Co., Ltd. (hereinafter referred to as "Suqian Hospital"), recently received a tax treatment decision from the audit bureau of Suqian Taxation Bureau of the State Administration of Taxation, stating that Suqian Hospital is required to pay a total of 8.4115 million yuan in taxes and late fees for the years 2022 to 2024. As of the date of this announcement, the above-mentioned taxes and late fees have all been paid in full, and this incident does not involve any administrative penalties.

Jinling Pharmaceutical (000919.SZ) announced that its subsidiary, Nanjing Gulou Hospital Group Suqian Hospital Co., Ltd. (hereinafter referred to as "Suqian Hospital"), recently received a tax handling decision from the Tax Inspection Bureau of the Suqian Taxation Bureau of the State Administration of Taxation. In accordance with the requirements of the tax authorities, Suqian Hospital is required to pay a total of 8.4115 million yuan in taxes and late fees for the period from 2022 to 2024. As of the date of this announcement, the above-mentioned taxes and late fees have been fully paid, and this does not involve administrative penalties.

China Galaxy (06881): Qu Yanping was elected as an executive director.

BAIRONG-W (06608) purchased approximately 800,000 shares at a cost of approximately HK$9.01 million on February 12th.

Xiaomi (01810) spent HKD 148 million on February 12 to repurchase 4.05 million shares.

China Galaxy (06881): Qu Yanping was elected as an executive director.

BAIRONG-W (06608) purchased approximately 800,000 shares at a cost of approximately HK$9.01 million on February 12th.

Xiaomi (01810) spent HKD 148 million on February 12 to repurchase 4.05 million shares.